Return On Equity	(Oct 31 2025) 2025	(Oct 31 2024) 2024	(Oct 31 2023) 2023
Y / Y Equity Change	-38.48 %	276.09 %	-	-	-
Y / Y Net Income Change	112.73 %	-49.67 %	-	-	-
Return On Equity	69.94 %	20.23 %	151.15 %	-	-

ENGN all Ratios >> Back to ENGN Management Effectiveness >> See Quarterly ENGN Return On Equity

You need to upgrade your Flash Player

Roe Comment

In (Oct 31 2025) ROE improved to 69.94 % compare to previous year, due to net income growth.

Financial Statements
Engene Therapeutics Inc 's Equity	$ 168 Millions	Annual ENGN's Balance sheet
Engene Therapeutics Inc 's Annual Income	$ 117 Millions	Annual ENGN's Income Statement
Where are ENGN's Income coming from?		Visit ENGN's Income by Segment

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.